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PATIENTS WITH A HISTORY OF OBESITY OR 
OVERWEIGHT, THEIR TREATMENT, AND 
ASSOCIATED COMORBIDITIES
Starling A, Gaskin M, Harrison P, Thorington N
Disease Treatment and Outcomes Group, IMS HEALTH, 
Middlesex, England
OBJECTIVES: To identify the number of UK patients
who have had a record of obesity or overweight in their
primary care data, together with the treatments em-
ployed, and associated comorbidities.
METHODS: This study used UKPCD which contains lon-
gitudinal records of nearly 2 million patients. Data are
captured daily from General Practitioners using AAH
Meditel System 5 software as part of their standard record
keeping. Patients were selected according to the primary
care coding system “Read” (entered as a problem or prob-
lem-linked note code), or prescribed therapy, from Janu-
ary 1992 to September 1998. Therapies and comorbidities
were extracted from these patients’ records.
RESULTS: Of all the active patients included in the Me-
diPlus database, 22.30% (95% CI 22.20–22.38) had a
mention of obesity or overweight in their patient record.
Of these obese and overweight patients, 1.26% (95% CI
1.22–1.31) were prescribed an anti-obesity drug and
1.87% (95% CI 1.82–1.93) were advised to follow a reg-
imen of diet and/or exercise. The top five comorbidities
most commonly associated with obesity/overweight were
(percentage of the obese/overweight population): hyper-
tension, 97.12% (95% CI 96.97–97.12); arthritis, 58.08%
(95% CI 57.82–58.24); IHD, 23.36% (95% CI 23.18–
23.55); COPD, 18.42% (95% CI 18.25–18.59); diabetes
mellitus, 5.88% (95% CI 5.78–5.99).
CONCLUSION: This study is an example of the use of an
automated, observational, primary care database such as
MediPlus in pharmacoeconomic and outcomes research.
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It has been well documented that atrial fibrillation (AF)
leads to serious consequences for many who suffer from
it. This has presupposed that conversion to, and mainte-
nance of, normal sinus rhythm (NSR) is beneficial.
OBJECTIVE: The purpose of this study was to compare
the long-term benefits associated with NSR compared
with AF.
METHODS: A state-transition model was developed
which compares an AF cohort to a converted population
in NSR with otherwise identical characteristics. Conse-
quences were grouped into three categories: symptoms
(e.g., palpitation), moderate events/states (e.g., angina),
major events/states (e.g., stroke). In addition, reversion to
AF was allowed for the NSR cohort. Rates of conse-
quences were identified through a review of the literature
and clinical trial data. Cost estimates for all consequences
and maintenance therapy (but not for conversion) were de-
veloped based on data from five all-payer, state discharge
databases using ICD-9 codes to identify disease and proce-
dure level data. These sources were supplemented by fee
schedules, other agency and survey data and the literature.
All costs are reported in 1998 US dollars, adjusted for
medical inflation and cost-to-charge ratios.
RESULTS: Life expectancy increases 1104 years (LYG)
for the 1000 person NSR cohort at a reduced cost of
$3323 per patient. These savings result from 31.9 fewer
major adverse events (death, stroke, ICH). Additionally,
NSR patients are expected to experience 14–33% fewer
days AF-related with symptoms per year.
CONCLUSION: This study suggests that there are sub-
stantial economic and health benefits to converting and
maintaining AF patients in NSR. There remains, how-
ever, a need to study the long term effects in a converted
NSR population as the only available data, to date, are
for native NSR populations.
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Growing pressure on mental healthcare providers and
managed care organizations to document the effective-
ness of their treatments requires linking improvements in
the process of care with measurement of the outcomes of
care. Outcomes assessment in psychiatry has previously
focused mainly upon specific conditions (such as anxiety
disorders or depression).
OBJECTIVE: We sought to develop a scale that would
be applicable across settings, treatments, and patient di-
agnoses, and would be meaningful to clinicians of differ-
ent theoretical persuasions. Using classical test theory
and Rasch item analysis, we developed a short scale de-
signed to measure the effectiveness of mental health treat-
ment across a wide range of mental health services and
populations.
METHODS: Item development for the scale was guided
by literature review, and interviews with senior clinicians
and patients. We used three different samples of inpa-
tients, outpatients, and non-patients for item reduction,
reliability analysis and validation (total n  257).
RESULTS: We reduced our initial item pool from 81 to
10 items. The 10-item scale had high internal consistency
(Cronbach’s alpha  .96), and showed strong correla-
tions with commonly used measures of psychological
well-being and distress. The Rasch characteristics of the
final 10-item scale were also good. The sample (subject)
